Navigation Links
RainDance Technologies to Dedicate New Headquarters, Manufacturing Facility in Lexington
Date:9/17/2008

- Biomedical technology innovator relocates to Mass. based upon Gov. Deval

Patrick's Life Sciences Initiative -
LEXINGTON, Mass., Sept. 17 /PRNewswire/ --

-- WHO: RainDance Technologies

-- WHAT: Dedication of its new HQ/manufacturing facility

-- WHEN: Friday, Sept. 26, 2008, 3:00 p.m. to 5:00 p.m. EDT

-- WHERE: 44 Hartwell Avenue, Lexington, Mass.

RainDance Technologies, Inc., a provider of innovative droplet-based microfluidic solutions for human health and disease research, will dedicate its new headquarters and commercial and manufacturing operations on Friday, Sept. 26th in Lexington, Mass. at 3:00 p.m.

RainDance's 28,000-square-foot building in Lexington will more than double its former space in Guilford, Conn. RainDance plans to increase its workforce by some 50 percent -- adding new biologists and chemists, mechanical engineers and technicians, software programmers, customer service representatives, and administrative support -- and will employ nearly 100 within the year.

Company officials made the decision to relocate to Massachusetts based on Governor Deval Patrick's Life Sciences Initiative.

RainDance will also announce a collaboration with a major pharmaceutical company to develop a new droplet-based methodology for the drug discovery process.

Agenda:

-- Remarks:

-- Sir Richard Roberts, Nobel Laureate, Physiology/ Medicine, 1993,

RainDance Technologies Scientific Advisory Board

-- Daniel O'Connell, Massachusetts Housing and Economic Development

Secretary

-- Christopher McNary, RainDance Technologies President and Chief

Executive Officer

-- A tour of our new facilities and reception will follow.

RainDance's new RainStorm(TM) droplet-based microfluidic technology has broad use in the prediction and prevention of human disease. The simplicity, speed, and capabilities of the technology will enable researchers to design experiments in ways previously unaffordable or unimaginable. RainStorm technology will find numerous uses in biomedical applications, including genomics research, gene expression analysis, compound screening, and biomarker detection.

RainDance was founded by scientists from Harvard University, the Medical Research Centre in Cambridge, England, and the ESPCI in Paris, and the company's scientific advisers include three Nobel Prize winners plus a pioneer in protein engineering who has been knighted for services to molecular biology.
Available Topic Expert(s): For information on the listed expert(s), click appropriate link. Steven Becker https://profnet.prnewswire.com/Subscriber/ExpertProfile.aspx?ei=78145


'/>"/>
SOURCE RainDance Technologies, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. RainDance and Scripps to Collaborate on Targeted Sequencing for Wellderly Study
2. RainDance Technologies Appoints Olex Vice President, System Development
3. RainDance Appoints Kelly Chief Operating Officer
4. RainDance Announces Company Relocation and Manufacturing Startup
5. RainDance Appoints Becker Chief Commercial Officer
6. RainDance Technologies Appoints McNary President and CEO
7. Microchip Biotechnologies, Inc. Awarded Contract Under US Army Commercialization Pilot Program
8. Tethys Bioscience Announces Acquisition of Lipomics Technologies
9. Althea Technologies Secures $12 M Credit Line to Continue Facility Growth and Expansion
10. Epeius Biotechnologies Lead Product, Rexin-G for Metastatic Cancer, Aptly Highlighted by National Cancer Institute Journal
11. Neptune Technologies decided not to re-price options
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/21/2017)... ... 20, 2017 , ... Nipro Corporation (Osaka, Japan) and Transonic Systems Inc. (New ... receive exclusive marketing and sales rights for all non-OEM Transonic products in Japan. As ... Japan, the new Nipro - Transonic JV is a natural next step to advance ...
(Date:1/21/2017)... , Jan. 21, 2017   Boston Biomedical , ... designed to target cancer stemness pathways, today presented data ... napabucasin, at the 2017 American Society of Clinical Oncology ... . In a Phase Ib/II ... designed to inhibit cancer stemness pathways by targeting STAT3 ...
(Date:1/20/2017)... ... January 20, 2017 , ... ... announced today the next evolution in spinal fusion, the MISquito Percutaneous Pedicle ... to the competition, SpineFrontier is focused on technique driven product solutions that ...
(Date:1/19/2017)... Research and Markets ... announced the addition of the "Implantable Biomaterials Market ... report to their offering. Report Highlights: ... analysis on current and future market trends to identify the investment opportunities ... the base numbers Key market trends across the business ...
Breaking Biology Technology:
(Date:1/12/2017)... research undertaken by Fit Small Business has revealed ... simply asked which office technology had they not used in ... Insights on what will be key features in ... industry leaders including Penelope Trunk , Martin Lindstrom ... Some of these findings included; ...
(Date:1/11/2017)... 2017 Intoxalock, a leading ignition interlock provider, ... its patent-pending calibration device. With this new technology, Intoxalock ... upload data logs and process repairs at service center ... "Fighting drunk driving through the application of cutting-edge technologies ... but also for the customer who can get back ...
(Date:1/6/2017)... 2017  Privately-held CalciMedica, Inc., announced that it ... of a novel calcium release-activated calcium (CRAC) channel ... Acute pancreatitis, sudden painful inflammation of ... can be very serious.  In severe cases it can ... hospital stays, time in the ICU and substantial ...
Breaking Biology News(10 mins):